Quantitative analysis of thrombomodulin-mediated conversion of protein C to APC: Translation from in vitro to in vivo

Journal of Immunological Methods

Volumn 384, Issue 1-2, 2012, Pages 21-24

  Carnemolla, Ronald ^a   Patel, Kruti Rajan ^a   Zaitsev, Sergei ^a   Cines, Douglas B ^a   Esmon, Charles T ^b   Muzykantov, Vladimir R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Activated protein C; Anti coagulant; Anti inflammatory; Antibody; ELISA; Protein C zymogen; Thrombin; Thrombomodulin

Indexed keywords

ACTIVATED PROTEIN C; PROTEIN C; THROMBIN; THROMBOMODULIN;

ANIMAL EXPERIMENT; ARTICLE; BIOTRANSFORMATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANIMALS; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME PRECURSORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; KINETICS; MALE; MICE; MICE, INBRED C57BL; PROTEIN BINDING; PROTEIN C; THROMBIN; THROMBOMODULIN;

ANIMALIA;

EID: 84865603232     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.06.012     Document Type: Article

References (10)

1. Abraham E., Laterre P.F., Garg R., et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N. Engl. J. Med. 2005, 353:1332.
2. Esmon C.T. Do-all receptor takes on coagulation, inflammation. Nat. Med. 2005, 11:475.
3. Fernandez J.A., Lentz S.R., Dwyre D.M., et al. A novel ELISA for mouse activated protein C in plasma. J. Immunol. Methods 2006, 314:174.
4. Li W., Zheng X., Gu J., et al. Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin. J. Thromb. Haemost. 2005, 3:1351.
5. Liaw P.C.Y., Ferrell G.L., Esmon C.T. A monoclonal antibody against activated protein C allows rapid detection of activated protein C in plasma and reveals a calcium ion dependent epitope involved in factor Va inactivation. J. Thromb. Haemost. 2003, 1:662.
6. Lindenauer P.K., Rothberg M.B., Nathanson B.H., et al. Activated protein C and hospital mortality in septic shock: a propensity-matched analysis. Crit. Care Med. 2010, 38:1101.
7. Sadaka F., O'Brien J., Migneron M., et al. Activated Protein C in septic shock: a prospenity-matched analysis. Crit. Care Med. 2011, 15:R89.
8. Van der Poll T., Levi M., Nick J.A., et al. Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans. Am. J. Respir. Crit. Care Med. 2005, 171:1125.
9. Weiler H., Isermann B.H. Thrombomodulin. J. Thromb. Haemost. 2003, 1:1515.
10. Yamakawa K., Fujimi S., Mohri T., et al. Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study. Crit. Care Med. 2011, 15:R123.